logo-loader

Full interview: Open Orphan confirms hVIVO deal is done

Published: 11:59 15 Jan 2020 GMT

Cathal Friel, CEO of Open Orphan announces that the hVIVO deal is finally in the bag and tells Proactive London what the timeline for shareholders now looks like.
News here on the Genomic Database and how Friel expects hVIVO to make a profit. Confirmation too on the slight musical chairs within management with Friel himself ceasing to be CEO and moving to a more 'hands on' Chairman's role. Friel explains a fundraiser is next and tells investors how he expects the revenue growth between both companies to grow.

hVIVO chairman Cathal Friel says he remains committed to hVIVO following...

hVIVO PLC (AIM:HVO) chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions while...

on 19/2/24